Where? Pennsylvania Convention Center, Philadelphia, PA, USA
CPhI North America returns to Philadelphia
Bigger, bolder, stronger: CPhI North America 2018 focuses on ‘Fostering Innovation in Drug Development and Manufacturing’.
Bertalan Meskó, a self-professed ‘geek physician’ with a PhD in genomics, envisions the impact of digital health technologies on the future of healthcare, helping patients, doctors, government regulators and companies work to make it a reality. At CPhI North America, his keynote address will focus on Science Fiction in Healthcare, and explore how science fiction becomes science fact, the role that patient-led design is having on technological developments, the new challenges presented by patients finding an unregulated, technological solution for health problems, how disruption is helping to tackle these new challenges, and how this is resulting in a cultural transformation as we move towards highly personalized, digital health solutions. Dr. Mesko’s keynote takes place on Tuesday 24th April from 1.30 pm to 2.15 pm.
Nik Leist is at the forefront of the digital health revolution, working to commercialize a new category of therapy: Digital Medicines. These offerings include widely-used drugs, formulated so they ‘communicate’ when they have been swallowed; a wearable patch that detects medicines and captures physiological responses; mobile applications to support patient self-care and physician decision-making; and data analytics to serve the needs of health system managers. In his keynote address, which takes place on Wednesday 25th April from 1:30 pm to 2:15 pm, Mr Leist will discuss how his teams develop integrated medication with sensors, wearable patches, and physiological algorithms that deliver the core functionality of Proteus’ FDA-approved Digital Medicines.
- Solubility enhancement and improving oral bioavailability
- Hot melt extrusion challenges and solutions
- Fixed dose combination (FDC) – a cost-effective approach for simplified dosing
- Precision medicine – changing the paradigm of drug development.
- Continuous processing technologies for API and intermediate manufacturing – innovation meeting market demand
- Fireside chat with Michael Levy, Head of Research & Innovation at USP: the role of quality standards in emerging technologies
- Regulatory considerations, strategy and best practices for choosing a quality contract manufacturing organization (CMO)
- Risk management in technology transfer.
- A molecule’s journey – breaking down roadblocks to commercial success
- USP standards to support qualification of raw materials and cell substrates for biomanufacturing
- Cell line development and new technologies
- Case study – implementing novel technologies to reduce timelines.
In addition to the keynote addresses and conference program, a series of Insight Briefings, in-depth seminars on technical and business topics, will be freely accessible to all exhibition visitors. Topics include accelerated drug approval programs, the digital transformation of the pharmaceutical industry, supply chain security advancements, amongst others. There will also be a number of free Exhibitor Showcases taking place, providing a platform for industry professionals to present forward-thinking perspectives on their key products, innovations and services. Finally, the pharmaceutical Serialization Series provide a forum for thought leaders to present and discuss the latest insights and developments within the serialization sector.
This year’s event has been expanded to introduce two new featured zones – the Bioprocessing Zone, with a focus on innovations in biopharmaceuticals, and the P-MEC Zone, a machinery zone to promote the latest technology in manufacturing equipment. The full zoning at CPhI North America now consists of:
Bioprocessing Zone: Consider these statistics – biopharmaceuticals currently generate global revenues of $162 billion. The biopharmaceutical market is projected to grow at CAGR 9.4% in the period 2017-2021, reaching $278 billion by 2021. Biomanufacturers will be spending more on innovation, increasing their budgets an expected 6% for new technologies. Outsourcing of biopharmaceutical manufacturing will continue to increase as companies aim to increase testing services and production efficiencies. New for 2018. The Bioprocessing Zone provides a specialized platform that showcases innovations and developments in this vital space, facilitating a one-stop-pharma-shop for companies to source for their requirements on manufacturing and processing.
CPhI Zone: With global pharmaceutical sales expected to grow at a CAGR of between 3% and 6%, fueled in part by a HPAPI and Generic APIs market estimated to reach $186 billion by 2020, and coupled with improved awareness for the environment, more sustainable ingredients, and better waste management, there are huge market opportunities in ingredients manufacturing. The CPhI Zone focuses in on these market trends and expansion opportunities to bring manufacturers, partners and customers together.
FDF Zone: Increased global demand for affordable prescription and OTC drugs are forcing the industry to manufacture high levels of safe, high quality, and cost-effective drugs efficiently. Focused on small and large molecules finished drug products, the FDF Zone highlights a wide variety of discussion areas relevant to the finished drug products market, including new business models, the ongoing convergence between drugs and devices, data intelligence, single-use systems, disposables, the increasing demand for generics, quality compliance, and regulatory scrutiny.
ICSE Zone: Home to 25% of the world’s pharmaceutical contract research and manufacturing, North America owns the largest market share of these vital services. The ICSE Drug Development Zone focused on pre-clinical and clinical research and drug development, providing the largest global stage for companies providing contract services across key areas such as clinical trials, contract research, contract manufacturing, biotech, IT, analytical services, packaging services, and logistics, amongst others.
InformEx Zone: Focused on fine and specialty chemicals, the InformEx Zone showcases the complete range of specialty chemicals and provides an opportunity for suppliers to connect with a broad spectrum of end use applications. It’s a marketplace designed to foster an environment for people of like interest to connect, learn, inspire, and become plugged into the centers of both the high-value chemical and pharma industries.
InnoPack Zone: Focused on the latest in packaging products and technology, the Innopack Zone provides a dedicated platform to showcase the latest and greatest innovations in this highly competitive space, highlighting both the opportunities and challenges associated creating sustainable, user-friendly packaging with innovative designs in a cost-effective way.
PMEC Zone: With the global pharmaceutical packaging machinery market expected to reach $8.25 billion by 2022, new industry regulations requiring reliable and high-end inspection technology equipment to be integrated into production lines, and manufacturers shifting to fully automated solutions to increase and improve efficiency and inspection accuracy, the P-MEC Machinery Zone brings together all the key role players involved with the science and technology used throughout the supply chain—from the production of API all the way to enclosing or protecting products for distribution, storage, sale, and use.